[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Paclitaxel Market in Malaysia - Manufacturing and Consumption, Outlook and Forecast 2020-2026

April 2020 | 105 pages | ID: P644502FCD4DEN
Market Monitor Global

US$ 2,700.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it 'taxol'.
This report contains market size and forecasts of Paclitaxel in Malaysia, including the following market information:
Malaysia Paclitaxel Market Revenue, 2015-2020, 2021-2026, ($ millions)
Malaysia Paclitaxel Market Consumption, 2015-2020, 2021-2026, (Kg)
Malaysia Paclitaxel Production Capacity, 2015-2020, 2021-2026, (Kg)
Top Five Competitors in Malaysia Paclitaxel Market 2019 (%)
The global Paclitaxel market was valued at 110.4 million in 2019 and is projected to reach US$ 152 million by 2026, at a CAGR of 8.3% during the forecast period. While the Paclitaxel market size in Malaysia was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Paclitaxel manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Paclitaxel production and consumption in Malaysia

Total Market by Segment:

Malaysia Paclitaxel Market, By Type, 2015-2020, 2021-2026 ($ millions) & (Kg)
Malaysia Paclitaxel Market Segment Percentages, By Type, 2019 (%)
  • Natural Paclitaxel API
  • Semi-synthetic Paclitaxel API
Malaysia Paclitaxel Market, By Application, 2015-2020, 2021-2026 ($ millions) & (Kg)
Malaysia Paclitaxel Market Segment Percentages, By Application, 2019 (%)
  • Ovarian Cancer
  • Cervical Cancer
  • Breast Cancer
  • Other
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Paclitaxel Market Competitors Revenues in Malaysia, by Players 2015-2020 (Estimated), ($ millions)
Total Paclitaxel Market Competitors Revenues Share in Malaysia, by Players 2019 (%)
Total Malaysia Paclitaxel Market Competitors Sales, by Players 2015-2020 (Estimated), (Kg)
Total Malaysia Paclitaxel Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
  • Phyton
  • ScinoPharm
  • Novasep
  • Samyang
  • Polymed
  • TAPI (Teva)
  • Fresenius-kabi
  • Huiang biopharma
  • Southpharma
  • Yunnan Hande
  • Hainan Yew Pharm
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Paclitaxel Market Definition
1.2 Market Segments
  1.2.1 Segment by Type
  1.2.2 Segment by Application
1.3 Malaysia Paclitaxel Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 COVID-19 IMPACT: MALAYSIA PACLITAXEL OVERALL MARKET SIZE

2.1 Malaysia Paclitaxel Market Size: 2020 VS 2026
2.2 Malaysia Paclitaxel Revenue, Prospects & Forecasts: 2015-2026
2.3 Malaysia Paclitaxel Sales (Consumption): 2015-2026

3 COMPANY LANDSCAPE

3.1 Top Paclitaxel Players in Malaysia (including Foreign and Local Companies)
3.2 Top Malaysia Paclitaxel Companies Ranked by Revenue
3.3 Malaysia Paclitaxel Revenue by Companies (including Foreign and Local Companies)
3.4 Malaysia Paclitaxel Sales by Companies (including Foreign and Local Companies)
3.5 Malaysia Paclitaxel Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Paclitaxel Companies in Malaysia, by Revenue in 2019
3.7 Malaysia Manufacturers Paclitaxel Product Type
3.8 Tier 1, Tier 2 and Tier 3 Paclitaxel Players in Malaysia
  3.8.1 List of Malaysia Tier 1 Paclitaxel Companies
  3.8.2 List of Malaysia Tier 2 and Tier 3 Paclitaxel Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Malaysia Paclitaxel Market Size Markets, 2020 & 2026
  4.1.2 Natural Paclitaxel API
  4.1.3 Semi-synthetic Paclitaxel API
4.2 By Type - Malaysia Paclitaxel Revenue & Forecasts
  4.2.1 By Type - Malaysia Paclitaxel Revenue, 2015-2020
  4.2.2 By Type - Malaysia Paclitaxel Revenue, 2021-2026
  4.2.3 By Type - Malaysia Paclitaxel Revenue Market Share, 2015-2026
4.3 By Type - Malaysia Paclitaxel Sales & Forecasts
  4.3.1 By Type - Malaysia Paclitaxel Sales, 2015-2020
  4.3.2 By Type - Malaysia Paclitaxel Sales, 2021-2026
  4.3.3 By Type - Malaysia Paclitaxel Sales Market Share, 2015-2026
4.4 By Type - Malaysia Paclitaxel Price (Manufacturers Selling Prices), 2015-2026

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Malaysia Paclitaxel Market Size, 2020 & 2026
  5.1.2 Ovarian Cancer
  5.1.3 Cervical Cancer
  5.1.4 Breast Cancer
  5.1.5 Other
5.2 By Application - Malaysia Paclitaxel Revenue & Forecasts
  5.2.1 By Application - Malaysia Paclitaxel Revenue, 2015-2020
  5.2.2 By Application - Malaysia Paclitaxel Revenue, 2021-2026
  5.2.3 By Application - Malaysia Paclitaxel Revenue Market Share, 2015-2026
5.3 By Application - Malaysia Paclitaxel Sales & Forecasts
  5.3.1 By Application - Malaysia Paclitaxel Sales, 2015-2020
  5.3.2 By Application - Malaysia Paclitaxel Sales, 2021-2026
  5.3.3 By Application - Malaysia Paclitaxel Sales Market Share, 2015-2026
5.4 By Application - Malaysia Paclitaxel Price (Manufacturers Selling Prices), 2015-2026

6 MANUFACTURERS & BRANDS PROFILES

6.1 Phyton
  6.1.1 Phyton Corporate Summary
  6.1.2 Phyton Business Overview
  6.1.3 Phyton Paclitaxel Major Product Offerings
  6.1.4 Phyton Sales and Revenue in Malaysia (2015-2020)
  6.1.5 Phyton Key News
6.2 ScinoPharm
  6.2.1 ScinoPharm Corporate Summary
  6.2.2 ScinoPharm Business Overview
  6.2.3 ScinoPharm Paclitaxel Major Product Offerings
  6.2.4 ScinoPharm Sales and Revenue in Malaysia (2015-2020)
  6.2.5 ScinoPharm Key News
6.3 Novasep
  6.3.1 Novasep Corporate Summary
  6.3.2 Novasep Business Overview
  6.3.3 Novasep Paclitaxel Major Product Offerings
  6.3.4 Novasep Sales and Revenue in Malaysia (2015-2020)
  6.3.5 Novasep Key News
6.4 Samyang
  6.4.1 Samyang Corporate Summary
  6.4.2 Samyang Business Overview
  6.4.3 Samyang Paclitaxel Major Product Offerings
  6.4.4 Samyang Sales and Revenue in Malaysia (2015-2020)
  6.4.5 Samyang Key News
6.5 Polymed
  6.5.1 Polymed Corporate Summary
  6.5.2 Polymed Business Overview
  6.5.3 Polymed Paclitaxel Major Product Offerings
  6.5.4 Polymed Sales and Revenue in Malaysia (2015-2020)
  6.5.5 Polymed Key News
6.6 TAPI (Teva)
  6.6.1 TAPI (Teva) Corporate Summary
  6.6.2 TAPI (Teva) Business Overview
  6.6.3 TAPI (Teva) Paclitaxel Major Product Offerings
  6.6.4 TAPI (Teva) Sales and Revenue in Malaysia (2015-2020)
  6.6.5 TAPI (Teva) Key News
6.7 Fresenius-kabi
  6.6.1 Fresenius-kabi Corporate Summary
  6.6.2 Fresenius-kabi Business Overview
  6.6.3 Fresenius-kabi Paclitaxel Major Product Offerings
  6.4.4 Fresenius-kabi Sales and Revenue in Malaysia (2015-2020)
  6.7.5 Fresenius-kabi Key News
6.8 Huiang biopharma
  6.8.1 Huiang biopharma Corporate Summary
  6.8.2 Huiang biopharma Business Overview
  6.8.3 Huiang biopharma Paclitaxel Major Product Offerings
  6.8.4 Huiang biopharma Sales and Revenue in Malaysia (2015-2020)
  6.8.5 Huiang biopharma Key News
6.9 Southpharma
  6.9.1 Southpharma Corporate Summary
  6.9.2 Southpharma Business Overview
  6.9.3 Southpharma Paclitaxel Major Product Offerings
  6.9.4 Southpharma Sales and Revenue in Malaysia (2015-2020)
  6.9.5 Southpharma Key News
6.10 Yunnan Hande
  6.10.1 Yunnan Hande Corporate Summary
  6.10.2 Yunnan Hande Business Overview
  6.10.3 Yunnan Hande Paclitaxel Major Product Offerings
  6.10.4 Yunnan Hande Sales and Revenue in Malaysia (2015-2020)
  6.10.5 Yunnan Hande Key News
6.11 Hainan Yew Pharm
  6.11.1 Hainan Yew Pharm Corporate Summary
  6.11.2 Hainan Yew Pharm Paclitaxel Business Overview
  6.11.3 Hainan Yew Pharm Paclitaxel Major Product Offerings
  6.11.4 Hainan Yew Pharm Sales and Revenue in Malaysia (2015-2020)
  6.11.5 Hainan Yew Pharm Key News
6.12 Jiangsu Yew Biotechnology
  6.12.1 Jiangsu Yew Biotechnology Corporate Summary
  6.12.2 Jiangsu Yew Biotechnology Paclitaxel Business Overview
  6.12.3 Jiangsu Yew Biotechnology Paclitaxel Major Product Offerings
  6.12.4 Jiangsu Yew Biotechnology Sales and Revenue in Malaysia (2015-2020)
  6.12.5 Jiangsu Yew Biotechnology Key News

7 PACLITAXEL PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS

7.1 Paclitaxel Production Capacity and Value in Malaysia, Situation Analysis and Prediction, 2015-2026
  7.1.1 Malaysia Paclitaxel Production Capacity, 2015-2026
  7.1.2 Malaysia Paclitaxel Production 2015-2026
  7.1.3 Malaysia Paclitaxel Production Value 2015-2026
7.2 Key Local Paclitaxel Manufacturers in Malaysia
  7.2.1 Malaysia Key Local Paclitaxel Manufacturers Production Capacity
  7.2.2 Malaysia Key Local Paclitaxel Manufacturers Production
  7.2.3 Malaysia Key Local Paclitaxel Manufacturers Production Value
  7.2.4 The Proportion of Paclitaxel Production Sold in Malaysia and Sold Other Than Malaysia by Manufacturers
7.3 Paclitaxel Export and Import in Malaysia
  7.3.1 Malaysia Paclitaxel Export Market
  7.3.2 Malaysia Paclitaxel Source of Imports

8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

8.1 PESTLE Analysis for Malaysia Paclitaxel Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints

9 COVID-19 IMPACT ON PACLITAXEL SUPPLY CHAIN ANALYSIS

9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
  9.4.1 Marketing Channels
  9.4.2 Paclitaxel Distributors and Sales Agents in Malaysia

10 CONCLUSION

11 APPENDIX

11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
LIST OF TABLES

Table 1. Key Players of Paclitaxel in Malaysia
Table 2. Top Players in Malaysia, Ranking by Revenue (2019)
Table 3. Malaysia Paclitaxel Revenue by Companies, (US$, Mn), 2015-2020
Table 4. Malaysia Paclitaxel Revenue Share by Companies, 2015-2020
Table 5. Malaysia Paclitaxel Sales by Companies, (Kg), 2015-2020
Table 6. Malaysia Paclitaxel Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Paclitaxel Price (2015-2020) (USD/Kg)
Table 8. Malaysia Manufacturers Paclitaxel Product Type
Table 9. List of Malaysia Tier 1 Paclitaxel Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of Malaysia Tier 2 and Tier 3 Paclitaxel Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Paclitaxel Revenue in Malaysia (US$, Mn), 2015-2020
Table 12. By Type - Paclitaxel Revenue in Malaysia (US$, Mn), 2021-2026
Table 13. By Type - Paclitaxel Sales in Malaysia (Kg), 2015-2020
Table 14. By Type - Paclitaxel Sales in Malaysia (Kg), 2021-2026
Table 15. By Application - Paclitaxel Revenue in Malaysia, (US$, Mn), 2015-2020
Table 16. By Application - Paclitaxel Revenue in Malaysia, (US$, Mn), 2021-2026
Table 17. By Application - Paclitaxel Sales in Malaysia, (Kg), 2015-2020
Table 18. By Application - Paclitaxel Sales in Malaysia, (Kg), 2021-2026
Table 19. Phyton Corporate Summary
Table 20. Phyton Paclitaxel Product Offerings
Table 21. Phyton Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 22. ScinoPharm Corporate Summary
Table 23. ScinoPharm Paclitaxel Product Offerings
Table 24. ScinoPharm Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 25. Novasep Corporate Summary
Table 26. Novasep Paclitaxel Product Offerings
Table 27. Novasep Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 28. Samyang Corporate Summary
Table 29. Samyang Paclitaxel Product Offerings
Table 30. Samyang Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 31. Polymed Corporate Summary
Table 32. Polymed Paclitaxel Product Offerings
Table 33. Polymed Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 34. TAPI (Teva) Corporate Summary
Table 35. TAPI (Teva) Paclitaxel Product Offerings
Table 36. TAPI (Teva) Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 37. Fresenius-kabi Corporate Summary
Table 38. Fresenius-kabi Paclitaxel Product Offerings
Table 39. Fresenius-kabi Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 40. Huiang biopharma Corporate Summary
Table 41. Huiang biopharma Paclitaxel Product Offerings
Table 42. Huiang biopharma Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 43. Southpharma Corporate Summary
Table 44. Southpharma Paclitaxel Product Offerings
Table 45. Southpharma Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 46. Yunnan Hande Corporate Summary
Table 47. Yunnan Hande Paclitaxel Product Offerings
Table 48. Yunnan Hande Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 49. Hainan Yew Pharm Corporate Summary
Table 50. Hainan Yew Pharm Paclitaxel Product Offerings
Table 51. Hainan Yew Pharm Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 52. Jiangsu Yew Biotechnology Corporate Summary
Table 53. Jiangsu Yew Biotechnology Paclitaxel Product Offerings
Table 54. Jiangsu Yew Biotechnology Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 55. Paclitaxel Production Capacity (Kg) of Local Manufacturers in Malaysia, 2015-2020
Table 56. Paclitaxel Production (Kg) of Local Manufacturers in Malaysia, 2015-2020
Table 57. Malaysia Paclitaxel Production Market Share of Local Manufacturers, 2015-2020
Table 58. Paclitaxel Production Value (US$, Mn) of Local Manufacturers in Malaysia, 2015-2020
Table 59. Malaysia Paclitaxel Production Value Market Share of Local Manufacturers, 2015-2020
Table 60. The Percentage of Paclitaxel Production Sold in Malaysia and Sold Other Than Malaysia by Manufacturers
Table 61. The Percentage of Paclitaxel Production Sold in Malaysia and Sold Other Than Malaysia by Manufacturers
Table 62. Dangeguojia Paclitaxel Sales (Consumption), Production, Export and Import, 2015-2020
Table 63. Raw Materials and Suppliers
Table 64. Paclitaxel Downstream Clients in Malaysia
Table 65. Paclitaxel Distributors and Sales Agents in Malaysia

LIST OF FIGURES

Figure 1. Paclitaxel Segment by Type
Figure 2. Paclitaxel Segment by Application
Figure 3. Dangeguojia Paclitaxel Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Paclitaxel Market Size in Malaysia, (US$, Mn) & (Kg): 2020 VS 2026
Figure 6. Malaysia Paclitaxel Revenue, 2015-2026 (US$, Mn)
Figure 7. Paclitaxel Sales in Malaysia: 2015-2026 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Paclitaxel Revenue in 2019
Figure 9. By Type - Malaysia Paclitaxel Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - Malaysia Paclitaxel Market Share, 2015-2020
Figure 11. By Type - Malaysia Paclitaxel Market Share, 2020-2026
Figure 12. By Type - Malaysia Paclitaxel Price (USD/Kg), 2015-2026
Figure 13. By Application - Paclitaxel Revenue in Malaysia (US$, Mn), 2020 & 2026
Figure 14. By Application - Malaysia Paclitaxel Market Share, 2015-2020
Figure 15. By Application - Malaysia Paclitaxel Market Share, 2020-2026
Figure 16. By Application -Malaysia Paclitaxel Price (USD/Kg), 2015-2026
Figure 17. Malaysia Paclitaxel Production Capacity (Kg), 2015-2026
Figure 18. Malaysia Paclitaxel Actual Output (Kg), 2015-2026
Figure 19. Malaysia Paclitaxel Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of Malaysia Paclitaxel Export Destination, 2019
Figure 21. The Source of Imports of Malaysia Paclitaxel, 2019
Figure 22. PEST Analysis for Malaysia Paclitaxel Market in 2020
Figure 23. Paclitaxel Market Opportunities & Trends in Malaysia
Figure 24. Paclitaxel Market Drivers in Malaysia
Figure 25. Paclitaxel Market Restraints in Malaysia
Figure 26. Paclitaxel Industry Value Chain


More Publications